TD Waterhouse Canada Inc. Cuts Position in HCA Healthcare, Inc. $HCA

TD Waterhouse Canada Inc. trimmed its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 12.6% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 12,885 shares of the company’s stock after selling 1,853 shares during the quarter. TD Waterhouse Canada Inc.’s holdings in HCA Healthcare were worth $5,490,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Sovran Advisors LLC boosted its stake in shares of HCA Healthcare by 1.0% during the third quarter. Sovran Advisors LLC now owns 2,278 shares of the company’s stock valued at $1,063,000 after purchasing an additional 22 shares during the period. Hemington Wealth Management raised its holdings in HCA Healthcare by 11.0% in the 3rd quarter. Hemington Wealth Management now owns 253 shares of the company’s stock worth $107,000 after purchasing an additional 25 shares in the last quarter. Abound Wealth Management boosted its position in HCA Healthcare by 28.0% during the 3rd quarter. Abound Wealth Management now owns 119 shares of the company’s stock valued at $51,000 after acquiring an additional 26 shares in the last quarter. Ballentine Partners LLC grew its stake in HCA Healthcare by 0.8% in the third quarter. Ballentine Partners LLC now owns 3,693 shares of the company’s stock worth $1,574,000 after purchasing an additional 29 shares during the period. Finally, Sivia Capital Partners LLC increased its stake in shares of HCA Healthcare by 5.5% in the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after acquiring an additional 33 shares in the last quarter. 62.73% of the stock is owned by institutional investors.

Insider Activity at HCA Healthcare

In related news, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the transaction, the executive vice president owned 3,487 shares in the company, valued at $1,652,105.73. The trade was a 52.74% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 1.30% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on HCA shares. Weiss Ratings reaffirmed a “buy (b)” rating on shares of HCA Healthcare in a research report on Monday, December 29th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of HCA Healthcare from $500.00 to $558.00 and gave the stock a “buy” rating in a research report on Wednesday. Sanford C. Bernstein reissued a “market perform” rating on shares of HCA Healthcare in a report on Wednesday. Raymond James Financial set a $525.00 target price on HCA Healthcare in a research report on Monday, October 27th. Finally, The Goldman Sachs Group lifted their price target on shares of HCA Healthcare from $520.00 to $558.00 and gave the company a “buy” rating in a report on Wednesday. Fifteen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $518.76.

HCA Healthcare Price Performance

NYSE:HCA opened at $488.19 on Friday. HCA Healthcare, Inc. has a 1 year low of $295.00 and a 1 year high of $527.55. The firm has a market capitalization of $111.40 billion, a price-to-earnings ratio of 17.20, a PEG ratio of 1.48 and a beta of 1.36. The business has a 50 day simple moving average of $481.07 and a 200-day simple moving average of $437.35.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, topping the consensus estimate of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The firm had revenue of $19.51 billion for the quarter, compared to the consensus estimate of $19.67 billion. During the same period in the prior year, the business posted $6.22 earnings per share. The company’s revenue for the quarter was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be given a $0.78 dividend. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Tuesday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s dividend payout ratio is presently 10.15%.

Key HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Strong quarterly results and market reaction — HCA reported an EPS beat and raised FY 2026 guidance, prompting coverage noting a gap up in the stock after the print. Shares Gap Up on Strong Earnings
• Positive Sentiment: Analysts boost targets and maintain bullish ratings — Goldman Sachs raised its price target to $558 (buy) and Leerink Partners increased its target to $573 (outperform), supporting further upside potential. Goldman Sachs Raises PT Leerink Raises PT TickerReport
• Positive Sentiment: Additional bullish analyst commentary — Truist and Deutsche Bank analysts publicly stated expectations for HCA shares to rise, reinforcing the buy-side momentum. Truist Note Deutsche Bank Note
• Positive Sentiment: Brand and quality recognition — Multiple HCA hospitals placed on Healthgrades’ America’s 50/100/250 Best Hospitals lists, supporting reputation and referral flows. Healthgrades Recognition
• Positive Sentiment: Outpatient growth and M&A runway — Company commentary and industry pieces highlight HCA’s push into outpatient facilities and acquisition opportunities, which investors view as margin?accretive growth. Outpatient Growth Acquisition Opportunities
• Positive Sentiment: Bullish research notes/coverage — Zacks highlights HCA as a strong growth stock based on style scores, adding to favorable retail/institutional sentiment. Zacks Growth Stock Piece
• Neutral Sentiment: Analysts say the narrative is shifting — Coverage explores how the investment story is evolving post?earnings/target resets; watch valuation vs. growth expectations. Analyst Narrative
• Neutral Sentiment: Local expansion and competitive landscape — Reporting on new ER builds and regional facility activity (e.g., southwest Florida) that may influence local market share dynamics. Local ER Story Freestanding EDs
• Negative Sentiment: Policy/regulatory risk — HCA is publicly noting it is monitoring federal policy shifts that could affect reimbursement or operations; this is a watcher for downside risk. Policy Risk

HCA Healthcare Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.